|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM360622968 |
003 |
DE-627 |
005 |
20231226083416.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2023.109729
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1202.xml
|
035 |
|
|
|a (DE-627)NLM360622968
|
035 |
|
|
|a (NLM)37562723
|
035 |
|
|
|a (PII)S1521-6616(23)00492-8
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Li, Zeying
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Elevated glucose metabolism driving pro-inflammatory response in B cells contributes to the progression of type 1 diabetes
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 02.10.2023
|
500 |
|
|
|a Date Revised 02.10.2023
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2023 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Type 1 diabetes (T1D) is an autoimmune disease characterized by the immune system's failure to maintain self-tolerance, resulting in the autoimmune destruction of pancreatic beta cells. Although T1D has conventionally been viewed as a T-cell-dominant disease, recent research has emphasized the contribution of B cells in the onset of the disease. However, the mechanism underlying aberrant B cell responses remains unknown. B cell metabolism is a crucial prerequisite for B cell function and the development of adaptive immune responses. Here, we investigated the metabolic features of B cells, first in a cross-sectional cohort and subsequently in non-obese diabetic (NOD) mice, and revealed that there is an increased frequency of high-glucose-avidity (2-NBDGhigh) B cell population that may contribute to T1D progression. Further characterization of the metabolic, transcriptional and functional phenotype of B cells in NOD mice found that elevated glucose avidity is associated with a greater capacity for co-stimulation, proliferation and inflammatory cytokine production. Mechanistically, elevated Myc signaling orchestrated the glucose metabolism and the pro-inflammatory response of B cells in T1D. In vitro experiments demonstrated that pharmacological inhibition of glucose metabolism using metformin and 2-DG reduced pro-inflammatory cytokine production and B cell proliferation. Moreover, the combination of these inhibitors successfully delayed insulitis development, onset of diabetes, and improved high blood glucose levels in streptozotocin (STZ)-induced diabetic mice model. Taken together, our work has uncovered these high-glucose-avidity B cells as novel adjuvant diagnostic and therapeutic targets for T1D
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Autoimmunity
|
650 |
|
4 |
|a B cells
|
650 |
|
4 |
|a Glucose metabolism
|
650 |
|
4 |
|a LADA
|
650 |
|
4 |
|a Metabolic inhibitors
|
650 |
|
4 |
|a Type 1 diabetes
|
650 |
|
7 |
|a Proto-Oncogene Proteins c-myc
|2 NLM
|
650 |
|
7 |
|a Cytokines
|2 NLM
|
650 |
|
7 |
|a Glucose
|2 NLM
|
650 |
|
7 |
|a IY9XDZ35W2
|2 NLM
|
700 |
1 |
|
|a Zhao, Mingjiu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Jingyue
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Luo, Wenjun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Juan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Gan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xie, Zhiguo
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xiao, Yang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Jiaqi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Xia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhao, Bin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhou, Zhiguang
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 255(2023) vom: 01. Okt., Seite 109729
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:255
|g year:2023
|g day:01
|g month:10
|g pages:109729
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109729
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 255
|j 2023
|b 01
|c 10
|h 109729
|